Specifically, NDUFA4 (AUC: 0.935), TFAM (AUC: 0.909), and CDKN1B (AUC: 0.911) demonstrated significant diagnostic value for NAFLD (Figure 7B). This evidence concerns the gene COXFA4 and metabolic dysfunction-associated steatotic liver disease.